Compare METCB & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | METCB | KOD |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 836.9M | 795.5M |
| IPO Year | N/A | 2018 |
| Metric | METCB | KOD |
|---|---|---|
| Price | $11.82 | $22.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $38.69 | $22.67 |
| AVG Volume (30 Days) | 96.0K | ★ 720.6K |
| Earning Date | 10-27-2025 | 11-13-2025 |
| Dividend Yield | ★ 6.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $579,503,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.86 | $1.92 |
| 52 Week High | $21.80 | $26.21 |
| Indicator | METCB | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 54.93 |
| Support Level | $11.10 | $21.24 |
| Resistance Level | $12.78 | $26.21 |
| Average True Range (ATR) | 0.85 | 1.67 |
| MACD | 0.08 | -0.16 |
| Stochastic Oscillator | 22.17 | 40.65 |
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.